AMINOSYN II 10% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
NDAINJECTIONINJECTABLE
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN II 10% W/ ELECTROLYTES is a parenteral nutrition solution containing amino acids, magnesium chloride, potassium chloride, potassium phosphate, and sodium chloride delivered by injection. It is used to provide essential amino acids and electrolytes to patients unable to meet nutritional needs orally or enterally, supporting protein synthesis and metabolic balance. This is a foundational supportive care product for critically ill, post-operative, and nutritionally compromised patients across hospital settings.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), suggesting mature market dynamics and potential team restructuring or transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN II offers career exposure in operations-heavy functions—manufacturing, quality assurance, supply chain, and engineering—reflecting the product's mature lifecycle and commodity-like market positioning. This role is ideal for professionals seeking to develop expertise in regulatory compliance, cost optimization, and hospital/institutional channel management rather than commercial growth or innovation.
Engineer
Worked on AMINOSYN II 10% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.